APP and Alzheimer disease: Soluble APP was also studied in MCI patients and it was observed that sAPPβ was higher in MCI patients that converted to AD compared with stable MCI patients, suggesting it may be a more accurate biomarker in AD diagnosis than Abeta42 [94,95].